Barrington Research Initiates Coverage On Viemed Healthcare with Outperform Rating, Announces Price Target of $14

Benzinga Newsdesk www.benzinga.com Positive 61.1%

Neg 0% Neu 0% Pos 61.1%

Barrington Research initiates coverage on Viemed Healthcare (NASDAQ:VMD) with a Outperform rating and announces Price Target of $14.